Day: May 27, 2020

Pulmotect, Inc., a clinical-stage biotechnology company, has received approval from the US Food & Drug Administration (FDA) to initiate two COVID-19 Phase-2 clinical trials of its innate immune stimulating drug PUL-042. The Company plans to start accrual within the next week at up to twenty U.S. sites. The trials are for the prevention of infection with SARS-CoV-2 and the prevention of disease progression in patients with early COVID-19 disease. Funding for the trials came from the final closing of the…

Anemia is properly diagnosed using a blood test that measures hemoglobin, but simply looking behind a patient’s eyelid can be a pretty good alternative if you know how red the tissue is supposed to be. Now, a team at Purdue University has developed a technology that lets a clinician use smartphone pictures of the inner eyelid to automatically obtain surprisingly accurate results of blood hemoglobin levels. This capability is expected to soon be fully integrated into an app that will…